Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

https://www.soho2019.com/

 

Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)
Avatar

CML-044 ENESTop 192-Weeks Results on Treatment-Free Remission in Chronic Phase CML After Stopping 2nd Line Nilotinib

By Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019) FEATURING Timothy P. Hughes
By Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019) FEATURING Timothy P. Hughes
0 views
November 18, 2019
Comments 0
Login to view comments. Click here to Login

Featured Video

08:18
Insights from 2023 ASH Annual Meeting

Treatment Strategies for Hematocrit Control in PV

Feat. A. Zhou

Featured Video

24:08
Indy Hematology Review

Evaluation, Diagnosis, Prognostication, and Emerging Therapies for M…

Feat. A. Tefferi
Chronic Myeloid Leukemia
17:08
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

CML State of the Art 2019: 2nd Generation TKIs Improve Molecular Out…

Feat. J. Cortés
15:28
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

Therapeutic Innovations in CML: Reducing Toxicity w/ Optimized Front…

Feat. M. Deininger
18:37
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

Impact of Depth and Duration of Response of TFR in CML: Current Reco…

Feat. D. Rea
12:22
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

Impact of Comorbidities in Treatment Choice of CML: TKI Toxicities N…

Feat. T. Hughes
15:19
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

29 y/o Male w/ CML: Allograft vs. 3rd Line Therapy - Transplant Is A…

Feat. M. Mauro
08:01
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

CML-044 ENESTop 192-Weeks Results on Treatment-Free Remission in Chr…

Feat. T. Hughes
13:11
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

Phase 1 CML-041 Results on Combination of Asciminib, a Novel and Spe…

Feat. M. Talpaz